Market Overview

Jim Cramer Advises His Viewers On Teva, AT&T And More

Related TEVA
Benzinga's Option Alert Recap From October 19
Benzinga's Option Alert Recap From October 16
Butensky & Cohen Financial Security, Inc Buys McKesson Corp, Expedia Inc, Sells E.I. ... (GuruFocus)
Related SGEN
The Market In 5 Minutes: Tax Overhaul In Focus As Senate Passes Budget Plan
Benzinga's Top Upgrades, Downgrades For October 20, 2017

On CNBC's "Mad Money Lightning Round", Jim Cramer said that he'ss not crazy about Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA). He added that investors who really want to buy it, should wait for Allergan plc Ordinary Shares (NYSE: AGN) to sell its stake in the company.

Cramer thinks that Seattle Genetics, Inc. (NASDAQ: SGEN) should be bought.

Walgreens Boots Alliance Inc (NASDAQ: WBA) is going to trade lower, when, Inc. (NASDAQ: AMZN) enters its business, thinks Cramer. He is tempted, but he wouldn't buy it. He would wait.

Benchmark Electronics, Inc. (NYSE: BHE) has a lot of cool devices and manufacturing designs, said Cramer. He likes the stock and he would buy it, but he believes it isn't cheap.

Cramer isn't a buyer of Snap Inc (NYSE: SNAP). He would wait until all the sellers clean out.

With all the changes the company is making, AT&T Inc. (NYSE: T) is a buy, said Cramer.

Posted-In: mad money Lightning RoundCNBC Jim Cramer Media


Related Articles (AMZN + AGN)

View Comments and Join the Discussion!

Partner Center